Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Chugh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2002 - 2005- University of MichiganResidency, Internal Medicine, 1998 - 2002
Washington University in St. Louis School of MedicineClass of 1998
Certifications & Licensure
MI State Medical License 2001 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Start of enrollment: 2005 Jul 01
- Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas Start of enrollment: 2005 Jun 01
- Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumors.Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian A Van Tine
Future Oncology. 2026-01-01 - Immunocompetent Murine Models Recapitulate the Heterogeneous Tumor-Immune Microenvironment of Human Liposarcoma.Amanda M Shafer, Emma Kenna, Lexi-Ann F Golden, Ahmed M Elhossiny, Kyle D Perry
Clinical Cancer Research. 2025-12-01 - Desmoid tumor control with liposomal doxorubicin: a dual-center retrospective analysis.Victoria Wytiaz, Rodney Dixon Dorand, Sean Cohen, Vicki Leigh Keedy, Scott C Borinstein
Expert Review of Anticancer Therapy. 2025-11-01
Other
- Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and stagingChugh R, Feng M, Sabel MS
http://www.uptodate.com/contents/breast-sarcoma-epidemiology-risk-factors-clinical-presentation-diag
UpToDate, Wolters Kluwer Health - 2012-11-19 - Breast sarcoma: TreatmentChugh R, Feng M, Sabel MS
http://www.uptodate.com/contents/breast-sarcoma-treatment
UpToDate, Wolters Kluwer Health - 2012-10-05 - Phyllodes tumors of the breastChugh R, Chakravarthy AB, Grau AM
http://www.uptodate.com/contents/phyllodes-tumors-of-the-breast
UpToDate, Wolters Kluwer Health - 2012-10-18
Press Mentions
Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (Devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, CalifSeptember 27th, 2021- For Ann Arbor Pastor Stacey Duke, and Many Other Patients with Cancer, the Pandemic Feels Far from OverJuly 16th, 2021
Unconditional Love and Radical AcceptanceMarch 24th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
